Katedra Higieny Żywności i Ochrony Zdrowia Konsumenta, Wydział Medycyny Weterynaryjnej, Uniwersytet Przyrodniczy we Wrocławiu, Wrocław
Bibliografia
1. Kloos W., Schleifer K.: Staphylococcus. W: Holt J. (red.): Bergey’s Manual of Systematic Bacteriology. Williams &Wilkins. USA 1986.
2. Lowy F.: Staphylococcus aureus infections. N. Engl. J. Med. 1998, 339, 520-532.
3. Otto M.: Basis of virulence in community-associated methicillin- resistant Staphylococcus aureus. Annu. Rev. Microbiol.2010, 64, 143-162.
4. Bhargava K., Zhang Y.: Multidrug-resistant coagulase- negative Staphylococci in food animals. J. Appl. Microbiol.2012, 113, 1027-1036.
5. Wertheim H., Melles D., Vos M., van Leeuwen W., van Belkum A., Verbrugh H., Nouwen J.: The role of nasal carriagein Staphylococcus aureus infections. Lancet Infect.Dis. 2005, 5, 751-762.
6. Rehm S.: Staphylococcus aureus: the new adventures of a legendary pathogen. Cleve. Clin. J. Med. 2008, 75, 177-192.
7. Le Loir Y., Baron F., Gautier M.: Staphylococcus aureus and food poisoning. Genet. Mol. Res. 2003, 2, 63-76.
8. Hennekinne J., de Buyser M., Dragacci S.: Staphylococcus aureus and its food poisoning toxins: characterizationand outbreak investigation. FEMS Microbiol. Rev.2012, 36, 815-836.
9. Kloos W., Bannerman T.: Update on clinical significance of coagulase-negative staphylococci. Clin. Microbiol.Rev. 1994, 7,117-140.
10. Gottlieb G., Fowler V. Jr, Kong L., McClelland R., Gopal A., Marr K., Li J., Sexton D., Glower D., Corey G.: Staphylococcusaureus bacteremia in the surgical patient: a prospectiveanalysis of 73 postoperative patients who developedStaphylococcus aureus bacteremia at a tertiary carefacility. J. Am. Coll. Surg. 2000, 190, 50-57.
11. Queck S., Otto M.: Staphylococcus epidermidis and other Coagulase-Negative Staphylococci. W: Lindsay J. (red.):Staphylococcus. Molecular Genetics. Caister AcademicPress, Norfolk, UK 2008.
12. Crass B., Bergdoll M.: Involvement of coagulase-negative staphylococci in toxic shock syndrome. J Clin Microbiol.1986, 23, 43-45.
13. von Eiff C, Proctor R, Peters G. Coagulase-negative staphylococci. Pathogens have major role in nosocomial infections. Postgrad Med. 2001. 110:63-76.
14. Da Cunha M., Rugolo L., Lopes C.: Study of virulence factors in coagulase-negative staphylococci isolated fromnewborns. Mem. Inst. Oswaldo Cruz. 2006, 101, 661-668.
15. von Eiff C., Arciola C., Montanaro L., Becker K., Campoccia D.: Emerging Staphylococcus species as new pathogensin implant infections. Int. J. Artif. Organs. 2006,29, 360-367.
16. Piette A., Verschraegen G.: Role of coagulase-negative staphylococci in human disease. Vet. Microbiol. 2009, 134, 45-54.
17. Irlinger F.: Safety assessment of dairy microorganisms: Coagulase-negative staphylococci. Int. J. Food. Microbiol.2008, 126, 302-310.
18. Podkowik M., Bystroń J., Bania J.: Genotypes, antibiotic resistance and virulence factors of staphylococci from ready-to-eat food. Foodborne Pathog. Dis. 2012a, 9, 91-93.
19. Podkowik M., Bystroń J., Bania J.: Prevalence of antibiotic resistance genes in staphylococci isolated fromready-to-eat meat products. Pol. J. Vet. Sci. 2012b, 15,233-237.
20. Saising J., Singdam S., Ongsakul M., Voravuthikunchai S.: Lipase, protease, and biofilm as the major virulence factorsin staphylococci isolated from acne lesions. Biosci.Trends. 2012, 6, 160-164.
21. Begović J., Jovčić B., Papić-Obradović M., Veljović K., Lukić J., Kojić M., Topisirović L.: Genotypic diversity and virulentfactors of Staphylococcus epidermidis isolated fromhuman breast milk. Microbiol. Res. 2013, 168, 77-83.
22. Hidron A., Edwards J., Patel J., Horan T., Sievert D., Pollock D., Fridkin S.: NHSN (National Healthcare Safety Network)annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annualsummary of data reported to the National HealthcareSafety Network at the Centers for Disease Control andPrevention, 2006-2007. Infect. Control Hosp. Epidemiol.2008, 29, 996-1011.
23. Hoen B., Alla F., Selton-Suty C., Béguinot I., Bouvet A., Briançon S., Casalta J., Danchin N., Delahaye F., Etienne J., Le Moing V., Leport C., Mainardi J., Ruimy R., Vandenesch F.: Changing profile of infective endocarditis: resultsof a 1-year survey in France. JAMA. 2002, 288, 75-81.
24. Rupp M., Archer L.: Coagulase-negative staphylococci: pathogens associated with medical progress. Clin. Infect.Dis. 1994, 9, 231-243.
25. Weese J.: Methicillin-resistant Staphylococcus aureus in animals. ILAR J. 2010, 51, 233-244.
26. Huber H., Ziegler D., Pflüger V., Vogel G., Zweifel C., Stephan R.: Prevalence and characteristics of methicillin-resistantcoagulase-negative staphylococci from livestock,chicken carcasses, bulk tank milk, minced meat, and contactpersons. BMC Vet. Res. 2011, 7, 6.
27. Kern A., Perreten V.: Clinical and molecular features of methicillin-resistant, coagulase-negative staphylococciof pets and horses. J. Antimicrob. Chemother. 2013, 68,1256-1266.
29. Mørk T., Jørgensen H., Sunde M., Kvitle B., Sviland S., Waage S., Tollersrud T.: Persistence of staphylococcal speciesand genotypes in the bovine udder. Vet. Microbiol. 2012, 159, 171-180.
30. Reyher K., Haine D., Dohoo I., Revie C.: Examining the effect of intramammary infections with minor mastitispathogens on the acquisition of new intramammary infectionswith major mastitis pathogens-a systematic reviewand meta-analysis. J. Dairy Sci. 2012, 95, 6483-6502.
31. Supré K., Haesebrouck F., Zadoks R., Vaneechoutte M., Piepers S., de Vliegher S.: Some coagulase-negative Staphylococcus species affect udder health more than others. J. Dairy Sci. 2011, 94, 2329-2340.
32. Moniri R., Dastehgoli K., Akramian A.: Increasing resistant coagulase negative staphylococci in bovine clinical mastitis. Pak. J. Biol. Sci. 2007, 10, 2465-2469.
33. Taponen S., Pyörälä S.: Coagulase-negative staphylococci as cause of bovine mastitis– not so different from Staphylococcusaureus? Vet. Microbiol. 2009, 134, 29-36.
34. Almeida R., Oliver S.: Interaction of coagulase-negative Staphylococcus species with bovine mammary epithelialcells. Microb. Pathog. 2001, 31, 205-212.
35. Kloos W., Musselwhite M.: Distribution and persistence of Staphylococcus and Micrococcus species and other aerobicbacteria on human skin. Appl. Microbiol. 1975, 30,381-385.
36. Otto M.: Staphylococcus epidermidis– the ‚accidental’ pathogen. Nat. Rev. Microbiol. 2009, 7, 555-567.
37. Raad I., Alrahwan A., Rolston K.: Staphylococcus epidermidis: emerging resistance and need for alternative agents.Clin. Infect. Dis. 1998, 26, 1182-1187.
38. von Eiff C., Peters G., Heilmann C.: Pathogenesis of infections due to coagulase-negative staphylococci. LancetInfect. Dis. 2002, 2, 677-685.
39. Cho S., Naber K., Hacker J., Ziebuhr W.: Detection of the icaADBC gene cluster and biofilm formation in Staphylococcusepidermidis isolates from catheter-related urinarytract infections. Int. J. Antimicrob. Agents. 2002, 19,570-575.
40. Otto M.: Staphylococcal infections: mechanisms of biofilm maturation and detachment as critical determinantsof pathogenicity. Annu. Rev. Med. 2013b, 64, 175-188.
41. Gagnon R., Richards G., Kostiner G.: Time-kill efficacy of antibiotics in combination with rifampin against Staphylococcusepidermidis biofilms. Adv. Perit. Dial. 1994,10, 189-192.
42. Curtin J., Cormican M., Fleming G., Keelehan J., Colleran E.: Linezolid compared with eperezolid, vancomycin,and gentamicin in an in vitro model of antimicrobial locktherapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob. Agents Chemother.2003, 47, 3145-3148.
43. De Silva G., Kantzanou M., Justice A., Massey R., Wilkinson A., Day N., Peacock S.: The ica operon and biofilmproduction in coagulase-negative Staphylococci associatedwith carriage and disease in a neonatal intensivecare unit. J. Clin. Microbiol. 2002, 40, 382-388.
44. Vandecasteele S., Peetermans W., Merckx R., Van Eldere J.: Expression of biofilm-associated genes in Staphylococcusepidermidis during in vitro and in vivo foreignbody infections. J. Infect. Dis. 2003, 188, 730-737.
45. Ziebuhr W., Heilmann C., Götz F., Meyer P., Wilms K., Straube E., Hacker J.: Detection of the intercellular adhesiongene cluster (ica) and phase variation in Staphylococcusepidermidis blood culture strains and mucosalisolates. Infect. Immun. 1997, 65, 890-896.
46. Heilmann C., Hussain M., Peters G., Götz F.: Evidence for autolysin-mediated primary attachment of Staphylococcusepidermidis to a polystyrene surface. Mol. Microbiol.1997, 24, 1013-1024.
47. Mack D., Davies A., Harris L., Rohde H., Horstkotte M., Knobloch J.: Microbial interactions in Staphylococcusepidermidis biofilms. Anal. Bioanal. Chem. 2007, 387,399‑408.
48. Byrne M., Rouch D., Skurray R.: Nucleotide sequence analysis of IS256 from the Staphylococcus aureus gentamicin-tobramycin-kanamycin-resistance transposonTn4001. Gene. 1989, 81, 361-367.
49. Gu J., Li H., Li M., Vuong C., Otto M., Wen Y., Gao Q.: Bacterial insertion sequence IS256 as a potential molecularmarker to discriminate invasive strains from commensalstrains of Staphylococcus epidermidis. J. Hosp. Infect.2005, 61, 342-348.
50. Ziebuhr W., Krimmer V., Rachid S., Lössner I., Götz F., Hacker J.: A novel mechanism of phase variation of virulence in Staphylococcus epidermidis: evidence for control of the polysaccharide intercellular adhesin synthesis by alternating insertion and excision of the insertion sequence element IS256. Mol. Microbiol. 1999, 32, 345-356.
51. Couto I., Wu S., Tomasz A., de Lencastre H.: Development of methicillin resistance in clinical isolates of Staphylococcussciuri by transcriptional activation of the mecAhomologue native to the species. J. Bacteriol. 2003, 185,645-653.
52. Jansen A., Türck M., Szekat C., Nagel M., Clever I., Bierbaum G.: Role of insertion elements and yycFG in the development of decreased susceptibility to vancomycin in Staphylococcus aureus. Microbiol. Infect. 2003, 9, 114-119.
53. Ziebuhr W., Dietrich K., Trautmann M., Wilhelm M.: Chromosomal rearrangements affecting biofilm productionand antibiotic resistance in a Staphylococcus epidermidisstrain causing shunt-associated ventriculitis. Int. J.Med. Microbiol. 2000, 290, 115-120.
54. Diep B., Gill S., Chang R., Phan T., Chen J., Davidson M., Lin F., Lin J., Carleton H., Mongodin E., Sensabaugh G., Perdreau-Remington F.: Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet. 2006, 367,731-739.
55. Thurlow L., Joshi G., Clark J., Spontak J., Neely C., Maile R., Richardson A:. Functional modularity of the argininecatabolic mobile element contributes to the successof USA300 methicillin-resistant Staphylococcus aureus.Cell Host Microbe. 2013, 13, 100-107.
56. Alonzo F., Torres V.: A lesson in survival: S. aureus versus the skin. Cell Host Microbe. 2013, 13, 3-5.
57. Miragaia M., de Lencastre H., Perdreau-Remington F., Chambers H., Higashi J., Sullam P., Lin J., Wong K., KingK., Otto M., Sensabaugh G., Diep B.: Genetic diversity ofarginine catabolic mobile element in Staphylococcus epidermidis.PLoS One. 2009, 4, e7722.
58. Rountree P., Freeman B.: Infections caused by a particular phage type of Staphylococcus aureus. Med. J. Aust. 1955,42, 157-161.
59. Wang X., Noble L., Kreiswirth B., Eisner W., McClements W., Jansen K., Anderson A.: Evaluation of a multilocus sequence typing system for Staphylococcus epidermidis. J.Med. Microbiol. 2003, 52, 989-998.
60. Thomas J., Vargas M., Miragaia M., Peacock S., Archer G., Enright M.: Improved multilocus sequence typing schemefor Staphylococcus epidermidis. J. Clin. Microbiol. 2007,45, 616-619.
61. Miragaia M., Couto I., de Lencastre H.: Genetic diversity among methicillin-resistant Staphylococcus epidermidis(MRSE). Microb. Drug. Resist. 2005, 11, 83-93.
62. Miragaia M., Couto I., Pereira S., Kristinsson K., Westh H., Jarløv J., Carriço J., Almeida J., Santos– Sanches I., deLencastre H.: Molecular characterization of methicillin-resistant Staphylococcus epidermidis clones: evidence of geographic dissemination. J. Clin. Microbiol. 2002, 40,430-438.
63. Otto M.: Coagulase-negative staphylococci as reservoirs of genes facilitating MRSA infection: Staphylococcalcommensal species such as Staphylococcus epidermidisare being recognized as important sources of genes promotingMRSA colonization and virulence. Bioessays.2013a, 35, 4-11.
64. Jaffe H., Sweeney H., Nathan C., Weinstein R., Kabins S., Cohen S.: Identity and interspecific transfer of gentamicin-resistance plasmids in Staphylococcus aureus and Staphylococcusepidermidis. J. Infect. Dis. 1980, 141, 738-747.
65. Otto M.: Virulence factors of the coagulase-negative staphylococci. Front. Biosci. 2004, 9, 841-863.
66. Marraffini L., Sontheimer E.: CRISPR interference limits horizontal gene transfer in staphylococci by targetingDNA. Science. 2008, 322, 1843-1845.
67. Bellamy R., Barkham T.: Staphylococcus lugdunensis infection sites: predominance of abscesses in the pelvic girdleregion. Clin. Infect. Dis. 2002, 35, 32-34.
68. Choi S., Chung J., Lee E., Kim T., Lee M., Kang J., Song E., Jun J., Kim M., Kim Y., Woo J., Choi S.: Incidence, characteristics,and outcomes of Staphylococcus lugdunensis bacteremia. J. Clin. Microbiol. 2010, 48, 3346-3349.
69. Ronald A.: The etiology of urinary tract infection: traditional and emerging pathogens. Am. J. Med. 2002, 113,14-19.
70. Gatermann S., Marre R.: Cloning and expression of Staphylococcus saprophyticus urease gene sequences in Staphylococcuscarnosus and contribution of the enzyme tovirulence. Infect. Immun. 1989, 57, 2998-3002.
71. Veach L., Pfaller M., Barrett M., Koontz F., Wenzel R:. Vancomycin resistance in Staphylococcus haemolyticuscausing colonization and bloodstream infection. J. Clin.Microbiol. 1990, 28, 2064-2068.
72. Rodríguez-Aranda A., Daskalaki M., Villar J., Sanz F., Otero J., Chaves F.: Nosocomial spread of linezolid-resistantStaphylococcus haemolyticus infections in an intensivecare unit. Diagn. Microbiol. Infect. Dis. 2009, 63,398-402.
73. Shinabarger D.: Mechanism of action of oxazolidinone antibacterial agents. Expert. Opin. Investig. Drugs. 1999,8, 1195-2002.
74. Doyle M., Hartmann F., Lee Wong A.: Methicillin-resistant staphylococci: implications for our food supply?Anim. Health Res. Rev. 2012, 13, 157-180.
75. Aarestrup F.: Association between the consumption of antimicrobial agents in animal husbandry and the occurrenceof resistant bacteria among food animals. Int.J. Antimicrob. Agents. 1999, 12, 279-285.
76. Mazel D, Davies J.: Antibiotic resistance in microbes. Cell. Mol. Life. Sci. 1999, 56, 742-754.
77. Aarestrup F., Wegener H., Collignon P.: Resistance in bacteria of the food chain: epidemiology and control strategies.Expert. Rev. Anti. Infect. Ther. 2008, 6, 733-750.
78. Simeoni D., Rizzotti L., Cocconcelli P., Gazzola S., Dellaglio F., Torriani S.: Antibiotic resistance genes and identification of staphylococci collected from the productionchain of swine meat commodities. Food Microbiol. 2008,25, 196-201.
79. Kluytmans J., van Leeuwen W., Goessens W., Hollis R., Messer S., Herwaldt L., Bruining H., Heck M., Rost J., vanLeeuwen N.: Food-initiated outbreak of methicillin resistantStaphylococcus aureus analyzed by phenol and genotyping.J. Clin. Microbiol. 1995, 33, 1121-1128.
80. Wu S., Piscitelli C., de Lencastre H., Tomasz A.: Tracking the evolutionary origin of the methicillin resistance gene: cloning and sequencing of a homologue of mecA from a methicillin susceptible strain of Staphylococcussciuri. Microb. Drug Resist. 1996, 2, 435-441.
81. Resch M., Nagel V., Hertel C.: Antibiotic resistance of coagulase- negative staphylococci associated with food andused in starter cultures. Int. J. Food Microbiol. 2008, 127,99-104.
82. Urdez-Hernández E., Sifuentes-Osornio J., Calva J., Villalobos- Zapata Y.: Epidemiological and biological characteristics of methicillin-resistant staphylococcal infections in a Mexican hospital. Arch. Med. Res. 1999, 30, 325-331.
83. Fontes C., Silva V., de Paiva M., Garcia R., Resende J., Ferreira- Machado A., Diniz C.: Prevalence, antimicrobial resistance,and virulence characteristics of mecA-encodingcoagulase-negative staphylococci isolated from soft cheesein Brazil. J. Food Sci. 2013, 78, 594-599.
84. Watanakunakorn C.: Antibiotic tolerance of Staphylococcus epidermidis. Scand. J. Infect. Dis. 1985, 17, 59-61.
85. Walsh T., Bolmström A., Qwärnström A., Ho P., Wootton M., Howe R., MacGowan A., Diekema D.: Evaluation ofcurrent methods for detection of staphylococci with reducedsusceptibility to glycopeptides. J. Clin. Microbiol.2001, 39, 2439-2444.
86. Natoli S., Fontana C., Favaro M., Bergamini A., Testore G., Minelli S., Bossa M., Casapulla M., Broglio G., BeltrameA., Cudillo L., Cerretti R., Leonardis F.: Characterization of coagulase-negative staphylococcal isolatesfrom blood with reduced susceptibility to glycopeptidesand therapeutic options. BMC Infect. Dis. 2009,9, 83.
87. Ma X., Wang E., Liu Y., Luo E.: Antibiotic susceptibility of coagulase-negative staphylococci (CoNS): emergenceof teicoplanin-non-susceptible CoNS strains withinducible resistance to vancomycin. J. Med. Microbiol.2011, 60, 1661-1668.
88. Forbes B., Schaberg D.: Transfer of resistance plasmids from Staphylococcus epidermidis to Staphylococcus aureus: evidence for conjugative exchange of resistance. J. Bacteriol. 1983, 153, 627-634.
89. Hanssen A., Kjeldsen G., Sollid J.: Local variants of Staphylococcal cassette chromosome mec in sporadicmethicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococci: evidenceof horizontal gene transfer? Antimicrob. AgentsChemother. 2004, 48, 285-296.
90. Kassem I.: Chinks in the armor: the role of the nonclinical environment in the transmission of Staphylococcusbacteria. Am. J. Infect. Control. 2011, 39, 539-541.
91. Pantosti A.: Methicillin-resistant Staphylococcus aureus associated with animals and its relevance to humanhealth. Front. Microbiol. 2012, 3, 127.
93. Scallan E., Hoekstra R., Angulo F., Tauxe R., Widdowson M., Roy S., Jones J., Griffin P.: Foodborne illness acquiredin the United States– major pathogens. Emerg. Infect.Dis. 2011, 17, 7-15.
94. Thomas D., Jarraud S., Lemercier B., Cozon G., Echasserieau K., Etienne J., Gougeon M., Lina G., VandeneschF.: Staphylococcal enterotoxin-like toxins U2 and V, twonew staphylococcal superantigens arising from recombinationwithin the enterotoxin gene cluster. J. Immunol.2006, 74, 4724-4734.
95. Ortega E., Abriouel H., Lucas R., Gálvez A.: Multiple roles of Staphylococcus aureus enterotoxins: pathogenicity,superantigenic activity, and correlation to antibioticresistance. Toxins. 2010, 2, 2117-2131.
96. Wilson G., Seo K., Cartwright R., Connelley T., Chuang- Smith O., Merriman J., Guinane C., Park J., BohachG., Schlievert P., Morrison W., Fitzgerald J: A novel core genome-encoded superantigen contributes tolethality of community-associated MRSA necrotizingpneumonia. PLoS Pathog. 2011, 7, e1002271.
97. Bergdoll M.: Enterotoxins. W: Easman C., Adlam C. (red.) Staphylococci and Staphylococcal Infections. AcademicPress London, UK 1983.
98. Fraser J., Proft T.: The bacterial superantigen and superantigen- like proteins. Immunol. Rev. 2008, 225, 226-243.
99. Omori G., Kato Y.: A staphylococcal food poisoning caused by a coagulase-negative strain. Bilken’s J. 1959,2, 92.
100. Breckinridge J., Bergdoll M.: Outbreak of food-borne gastroenteritis due to a coagulase-negative enterotoxin-producing staphylococcus. N. Engl. J. Med. 1971,284, 541-543.
101. Podkowik M., Park J., Seo K., Bystroń J., Bania J.: Enterotoxigenic potential of coagulase-negative staphylococci.Int. J. Food. Microbiol. 2013, 163, 34-40.
102. Da Cunha M., Calsolari R., Júnior J.: Detection of enterotoxin and toxic shock syndrome toxin 1 genes inStaphylococcus, with emphasis on coagulase-negativestaphylococci. Microbiol. Immunol. 2007, 51, 381-390.
103. Barretti P., Montelli A., Batalha J., Caramori J., da Cunha M.: The role of virulence factors in the outcome ofstaphylococcal peritonitis in CAPD patients. BMC InfectDis. 2009, 9, 212.
104. Adesiyun A., Usman B.: Isolation of enterotoxigenic strains of staphylococci from dogs. Vet. Microbiol. 1983,8, 459-468.
105. Valle J., Gomez-Lucia E., Piriz S., Goyache J., Orden J., Vadillo S.: Enterotoxin production by staphylococciisolated from healthy goats. Appl. Environ. Microbiol.1990, 56, 1323-1326.
106. Unal N., Cinar O.: Detection of stapylococcal enterotoxin, methicillin-resistant and Panton-Valentine leukocidingenes in coagulase-negative staphylococci isolatedfrom cows and ewes with subclinical mastitis. Trop.Anim. Health. Prod. 2012, 44, 369-375.
107. Park J., Fox L., Seo K., McGuire M., Park Y., Rurangirwa F., Sischo W., Bohach G.: Detection of classical andnewly described staphylococcal superantigen genes incoagulase-negative staphylococci isolated from bovineintramammary infections. Vet. Microbiol. 2011, 147,149-154.
108. Bergonier D., de Crémoux R., Rupp R., Lagriffoul G., Berthelot X.: Mastitis of dairy small ruminants. Vet.Res. 2003, 34, 689-716.
109. Taponen S., Simojoki H., Haveri M., Larsen H., Pyörälä S.: Clinical characteristics and persistence of bovine mastitiscaused by different species of coagulase-negativestaphylococci identified with API or AFLP. Vet. Microbiol.2006, 115, 199-207.
110. Unal N., Yildirim M.: Antibiotic resistance profiles of staphylococci species isolated from milks, teat skins and noses mucous of cows. Kafkas Univ. Vet. Fak. Derg. 2010, 16, 389-396.
111. Oliveira A., Padovani C., Miya N., Sant’Ana A., Pereira J.: High incidence of enterotoxin D producing Staphylococcusspp. in Brazilian cow’s raw milk and its relationwith coagulase and thermonuclease enzymes. FoodbornePathog. Dis. 2011, 8, 159-163.
112. Bautista L., Gaya P., Medina M., Nuñez M.: A quantitative study of enterotoxin production by sheep milk staphylococci. Appl Environ Microbiol. 1988, 54, 566-569.
113. Contreras A., Luengo C., Sanchéz A., Corrales J.: The role of intramammary pathogens in dairy goats. Livest. Prod. Sci. 2003, 79, 273-283.
114. Harvey J., Gilmour A.: Application of current methods for isolation and identification of staphylococci in raw bovine milk. J. Appl. Bacteriol. 1985, 59, 207-221.
115. De Buyser M., Dilasser F., Hummel R., Bergdoll M.: Enterotoxin and toxic shock syndrome-1 productionby staphylococci isolated fromgoat’s milk. Int. J. Food.Microbiol. 1987, 5, 301-309.
116. Marín M., de la Rosa M., Cornejo I.: Enterotoxigenicity of Staphylococcus strains isolated from Spanishdry-cured hams. Appl. Environ. Microbiol. 1992, 58,1067‑1069.
117. Rodríguez M., Núñez F., Córdoba J., Bermúdez E., Asensio M.: Gram-positive, catalase-positive cocci from drycured Iberian ham and their enterotoxigenic potential.Appl. Environ. Microbiol. 1996, 62, 1897-1902.
118. Hammes W., Hertel C.: New developments in meat starter cultures. Meat Sci. 1998, 49, 5125-5138.
119. Zell C., Resch M., Rosenstein R., Albrecht T., Hertel C., Götz F.: Characterization of toxin production of coagulase-negative staphylococci isolated from food and starter cultures. Int. J. Food Microbiol. 2008, 127,246-251.
120. Udo E., Al-Bustan M., Jacob L., Chugh T.: Enterotoxin production by coagulase-negative staphylococci in restaurant workers from Kuwait City may be a potential cause of food poisoning. J. Med. Microbiol. 1999, 48, 819-823.